Velocity Clinical Research, a research organization, has purchased its first European site, Clinical Research Hamburg.

Velocity is the first US-based clinical research firm to expand into Europe, bringing its number of locations to 32.

Dominic Clavell, executive vice president of Europe, said, “For any clinical trials business, developing an EU presence is paramount to its success. Velocity Clinical Research is breaking new ground in the clinical research industry. This is the first time that research sites have truly integrated across America and Europe, with a common tech stack and centralized management team, which gives CROs and pharmaceutical companies simplified access to international research.”